Neonatal diabetes mellitus: Insights for more common forms of diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 10, 2007, Pages 3774-3776

  Polak, Michel ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLIPIZIDE; GLUCOSE DEHYDROGENASE; INSULIN; SULFONYLUREA; TOLBUTAMIDE;

DIABETES MELLITUS; DIARRHEA; DRUG SUBSTITUTION; EDITORIAL; GENE MUTATION; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INTRAUTERINE GROWTH RETARDATION; NEWBORN DISEASE; PHENOTYPE; PRIORITY JOURNAL;

EID: 35349005196     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1710     Document Type: Editorial

References (19)

1. Polak M, Cavé H2007 Neonatal diabetes mellitus: a disease linked to multiple mechanisms. Orphanet J Rare Dis Mar 9;2:12
2. Von Mühlendahl KE, Herkenhoff H 1995 Long-term course of neonatal diabetes. N Engl J Med 333:704-708
3. Metz C, Cave H, Bertrand AM, Deffert C, Gueguen-Giroux B, Czernichow P, Polak M; NDM French Study Group. Neonatal diabetes mellitus 2002 Neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases. J Pediatr 141:483-489
4. Temple IK, Gardner RJ, MacKay DJ, Barber JC, Robinson DO, Shield JP 2000 Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes 49:1359-1366
5. Shield JP, Baum JD 1995 Transient neonatal diabetes and later onset diabetes: a case of inherited insulin resistance. Arch Dis Child 72:56-57
6. Marquis E, Le Monnier de Gouville I, Bouvattier C, Robert JJ, Junien C, Charron D, Hors J, Diatloff-Zito C 2000 HLA-DRB1 and DQB1 genotypes in patients with insulin-dependent neonatal diabetes mellitus. A study of 13 cases. Tissue Antigens 56:217-222
7. Iafusco D, Stazi MA, Cotichini R, Cotellessa M, Martinucci ME, Mazzella M, Cherubini V, Barbetti F, Martinetti M, Cerutti F, Prisco F; Early Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology 2002 Permanent diabetes mellitus in the first year of life. Diabetologia 45:798-804
8. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JP, Sumnik Z, van Rhijn A, Wales JK, Clark P, Gorman S, Aisenberg J, Ellard S, Njølstad PR, Ashcroft FM, Hattersley AT 2004 Activating mutations in the gene encoding the ATP-sensitive potassium channel subunit Kir6.2 gene are associated and permanent neonatal diabetes. N Engl J Med 350:1838-1849
9. Vaxillaire M, Populaire C, Busiah K, Cavé H, Gloyn AL, Hattersley AT, Czernichow P, Froguel P, Polak M 2004 Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients. Diabetes 53:2719-2722
10. Massa O, Iafusco D, D'Amato E, Gloyn AL, Hattersley AT, Pasquino B, Tonini G, Dammacco F, Zanette G, Meschi F, Porzio O, Bottazzo G, Crino' A, Lorini R, Cerutti F, Vanelli M, Barbetti F; Early Onset Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetology 2005 KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Hum Mutat 25:22-27
11. Gloyn AL, Reimann F, Girard C, Edghill EL, Proks P, Pearson ER, Temple IK, Mackay DJ, Shield JP, Freedenberg D, Noyes K, Ellard S, Ashcroft FM, Gribble FM, Hattersley AT 2005 Relapsing diabetes can result from moderately activating mutations in KCNJ11. Hum Mol Genet 14:925-934
12. Gloyn AL, Cummings EA, Edghill EL, Harries LW, Scott R, Costa T, Temple IK, Hattersley AT, Ellard S 2004 Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the β-cell potassium adenosine triphosphate channel. J Clin Endocrinol Metab 89:3932-3935
13. Proks P, Antcliff JF, Lippiat J, Gloyn AL, Hattersley AT, Ashcroft FM 2004 Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features. Proc Natl Acad Sci USA 101:17539-17544
14. Babenko AP, Polak M, Cavé H, Busiah K, Czernichow P, Scharfmann R, Bryan J, Aguilar-Bryan L, Vaxillaire M, Froguel P 2006 Activating mutations in ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 355:456-466
15. Stanik J, Gasperikova D, Paskova M, Barak L, Javorkova J, Jancova E, Ciljakova M, Hlava P, Michalek J, Flanagan SE, Pearson E, Hattersley AT, Ellard S, Klimes I 2007 Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. J Clin Endocrinol Metab 92:1276-1282
16. Flanagan SE, Patch AM, Mackay DJ, Edghill EL, Gloyn AL, Robinson D, Shield JP, Temple K, Ellard S, Hattersley AT 2007 Mutations in KATP channel genes cause transient neonatal diabetes and permanent diabetes in childhood and adulthood. Diabetes 56:1930-1937
17. Vaxillaire M, Dechaume A, Busiah K, Cave H, Pereira S, Scharfmann R, de Nanclares GP, Castano L, Froguel P, Polak M; SUR1-Neonatal Diabetes Study Group 2007 New ABCC8 mutations in relapsing neonatal diabetes and clinical features. Diabetes 56:1737-1741
18. Suzuki S, Makita Y, Mukai T, Matsuo K, Ueda O, Fujieda K 2007 Molecular basis of neonatal diabetes in Japanese patients. J Clin Endocrinol Metab 92: 3980-3986
19. Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V, Slingerland AS, Shield J, Robert JJ, Holst JJ, Clark PM, Ellard S, Søvik O, Polak M, Hattersley AT; Neonatal Diabetes International Collaborative Group 2006 Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355:467-477